Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

29452 ARTÍCULOS , VIENDO DEL 2026 AL 2040

Strategies for measuring concentrations and forms of amyloid-β peptides

Shen H, Liu K, Kong F, Ren M, Wang X, Wang S.

Biosens Bioelectron. 2024 Sep 1;259:116405. doi: 10.1016/j.bios.2024.116405. Epub 2024 May 18.

Pericytes in Alzheimer's disease: Key players and therapeutic targets

Zhang Y, Mu BR, Ran Z, Zhu T, Huang X, Yang X, Wang DM, Ma QH, Lu MH.

Exp Neurol. 2024 Sep;379:114825. doi: 10.1016/j.expneurol.2024.114825. Epub 2024 May 21.

Vitamin D, Alzheimer's disease and related dementia

Shea MK, Xuan AY, Booth SL.

Adv Food Nutr Res. 2024;109:185-219. doi: 10.1016/bs.afnr.2023.12.003. Epub 2024 Jan 5.

Bio-Nano Toolbox for Precision Alzheimer's Disease Gene Therapy

Liu Y, Xia X, Zheng M, Shi B.

Adv Mater. 2024 Jul;36(29):e2314354. doi: 10.1002/adma.202314354. Epub 2024 May 22.

Complement C3aR signaling: Immune and metabolic modulation and its impact on Alzheimer's disease

Gedam M, Zheng H.

Eur J Immunol. 2024 Aug;54(8):e2350815. doi: 10.1002/eji.202350815. Epub 2024 May 22.

Amyloid, Crohn's disease, and Alzheimer's disease - are they linked?

Duda-Madej A, Stecko J, Szymańska N, Miętkiewicz A, Szandruk-Bender M.

Front Cell Infect Microbiol. 2024 May 8;14:1393809. doi: 10.3389/fcimb.2024.1393809. eCollection 2024.

Evidence for a novel neuronal mechanism driving Alzheimer's disease, upstream of amyloid

Garcia Ratés S, García-Ayllón MS, Falgàs N, Brangman SA, Esiri MM, Coen CW, Greenfield SA.

Alzheimers Dement. 2024 Jul;20(7):5027-5034. doi: 10.1002/alz.13869. Epub 2024 May 23.

Immunotherapeutic approaches for Alzheimer's disease: Exploring active and passive vaccine progress

Bhadane P, Roul K, Belemkar S, Kumar D.

Brain Res. 2024 Oct 1;1840:149018. doi: 10.1016/j.brainres.2024.149018. Epub 2024 May 21.

A potential new treatment for Alzheimer's disease … and other research

Nolan T.

BMJ. 2024 May 23;385:q1125. doi: 10.1136/bmj.q1125.

The donepezil transdermal system for the treatment of patients with mild, moderate, or severe Alzheimer's disease: a critical review

Buck A, Rezaei K, Quazi A, Goldmeier G, Silverglate B, Grossberg GT.

Expert Rev Neurother. 2024 Jun;24(6):607-614. doi: 10.1080/14737175.2024.2355981. Epub 2024 May 24.

A Scoping Review of Alzheimers Disease Hypotheses: An Array of Uni- and Multi-Factorial Theories

Duchesne S, Rousseau LS, Belzile-Marsolais F, Welch LA, Cournoyer B, Arseneau M, Lapierre V, Poulin SM, Potvin O, Hudon C.

J Alzheimers Dis. 2024;99(3):843-856. doi: 10.3233/JAD-230772.

Ferroptosis: A new strategy for targeting Alzheimer's disease

Qiang RR, Xiang Y, Zhang L, Bai XY, Zhang D, Li YJ, Yang YL, Liu XL.

Neurochem Int. 2024 Sep;178:105773. doi: 10.1016/j.neuint.2024.105773. Epub 2024 May 23.

Cannabinoid and Orexigenic Systems Interplay as a New Focus of Research in Alzheimer's Disease

Rebassa JB, Capó T, Lillo J, Raïch I, Reyes-Resina I, Navarro G.

Int J Mol Sci. 2024 May 15;25(10):5378. doi: 10.3390/ijms25105378.

Parvalbumin Interneuron Dysfunction in Neurological Disorders: Focus on Epilepsy and Alzheimer's Disease

Leitch B.

Int J Mol Sci. 2024 May 19;25(10):5549. doi: 10.3390/ijms25105549.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias